• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX, SA VITEK® MS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX, SA VITEK® MS Back to Search Results
Model Number 410895
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 10/18/2016
Event Type  malfunction  
Event Description
A customer in italy contacted biomérieux to report a misidentification of brucella melitensis as pseudomonas aeruginosa in association with the vitek® ms.Repeat testing with the vitek® ms produced the same identification.The customer tested the specimen (tss blood culture) with the vitek® 2, and the sample was identified as brucella melitensis.This vitek® 2 result was reported to the physician without delay, and there was no adverse impact to the patient's health.The customer stated the vitek® ms instrument was calibrated and fine tuning was performed on (b)(6) 2016.Biomerieux requested a culture sample, test reports from both vitek® systems, and the vitek® ms calibration and fine tuning analyzer reports.An internal biomérieux investigation has been initiated.
 
Manufacturer Narrative
Biomérieux conducted an internal investigation: the result obtained by vitek® 2 (brucella melitensis) is not included in the vitek® ms v2.0 knowledge base (kb) (current version) or v3.0 (version under deployment).The sample was tested four (4) times on vitek® ms (two (2) different spots shot two (2) times).Three (3) tests gave "noid" and one test gave pseudomonas aeruginosa.Ecal mzml files were provided and analyzed.The most probable root cause to the misidentification obtained by the customer is a spot preparation issue.It has been observed during investigation that the number of "all peaks" is heterogeneous for e.Coli (calibrant strain) (between 67 to 124 peaks).Moreover, regarding the sample, the number of "all peaks" was lower at the second reading of the spot (from 71 to 55 for spot j3 and from 54 to 48 for spot j4).There is a system limitation when the tested species is not in the vitek® ms knowledge base.Vitek® ms system identification is based on a species pattern classification.The system limitation is due to the use of a predictive modeling based on a supervised learning.Typically, such a model includes an algorithm that learns certain properties (peaks presence) from a training spectra dataset in order to make those predictions.When the microorganism tested is not part of the training dataset, no specific species pattern will be available in the database for comparison.Consequently, the system can give: no identification (most probable answer) when the spectrum acquired doesn't match with any species pattern - obtained three (3) times on the four (4) tests performed a low discrimination identification (often the same genus than expected) when the spectrum acquired presents high level of similarity with multiple specific species patterns present in the database.An incorrect single choice identification to the nearest pattern species (often same genus than expected) when the spectrum acquired presents high level of similarity with a specific species pattern present in the database.Note: the kb user manual ref.161150-556- b for vitek® ms clinical use v3.0 mentions the following limitations: "testing of species not found in the database may result in an unidentified result or a misidentification.Note: interpretation of results and use of the vitek® ms system require a competent laboratorian who should judiciously make use of experience, specimen information, and other pertinent procedures before reporting the identification of test organisms.Additional information known to the user, such as gram stain reaction, colonial and cellular morphology, and growth aerobically or in co2 should be considered when accepting vitek® ms results.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITEK® MS
Type of Device
VITEK® MS
Manufacturer (Section D)
BIOMERIEUX, SA
chemin de l orme
marcy l etoile, rhone 69280
FR  69280
Manufacturer (Section G)
BIOMERIEUX, SA
chemin de l orme
marcy l etoile, rhone 69280
FR   69280
Manufacturer Contact
ellen weltmer
595 anglum road
hazelwood, MO 63042
3147317301
MDR Report Key6123257
MDR Text Key60870341
Report Number3002769706-2016-00486
Device Sequence Number1
Product Code PEX
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
K124067
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 03/17/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Device Model Number410895
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/03/2016
Initial Date FDA Received11/22/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received03/17/2017
Was Device Evaluated by Manufacturer? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-